How China controls the Covid-19 epidemic through public health expenditure and policy?

被引:42
|
作者
Jin, Hui [1 ]
Li, Baoyang [1 ]
Jakovljevic, Mihajlo [2 ,3 ,4 ]
机构
[1] Zhejiang Sci Tech Univ, Sch Econ & Management, Hangzhou 310018, Peoples R China
[2] Peter Great St Petersburg Polytech Univ, Inst Adv Mfg Technol, St Petersburg, Russia
[3] Hosei Univ, Inst Comparat Econ Studies, Tokyo, Japan
[4] Univ Kragujevac, Fac Med Sci, Dept Global Hlth Econ & Policy, Kragujevac, Serbia
基金
中国国家社会科学基金;
关键词
Public health; China; COVID-19; government spending; public policy; policy analysis; CARE EXPENDITURE; SPENDING PATTERNS; MIX; INNOVATION; RESPONSES; IMPACT;
D O I
10.1080/13696998.2022.2054202
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims How the Chinese government controls the Covid-19 epidemic? This paper aims to answer this question from the perspective of public health expenditure, and policy, and then to help the government to perform better in infectious disease prevention and public health emergency management. Methods and materials We reviewed the development phases of the COVID-19 epidemic in China and divided it into four stages (incubation stage, outbreak stage, resolution stage, and stable stage). Then we adopted a content analysis method via MAXQDA2020, to analyze the combined application of four different types of policy tools in different stages with 571 texts of epidemic governance policy from the Chinese central government. We also calculated and compared the Chinese public health expenditure between epidemic and non-epidemic periods. Moreover, we also discussed implications for public health emergency management and for infectious disease prevention and control in China. Results (1) in the incubation stage, the potential epidemic has not attracted enough attention from the government; (2) the combination of the 4 types of policies is not only an important reason in controlling epidemic during the outbreak stage and resolution stage, but also the reason why the small-scale epidemic has not expanded in the stable stage; (3) the increasing Chinese public health expenditure, involving public health emergency treatment (114.81 billion yuan), government hospitals (284.84 billion yuan) and major public health service projects (45.33 billion yuan), is another critical reason for the rapid control of the epidemic. Conclusion and implications Public health expenditure and policy played an important role in the governance and control of the COVID-19 epidemic in China. Some limitations of China's infectious disease prevention system and public health emergency management system have been exposed to the public in this epidemic, which the Chinese government needs to improve in the future.
引用
收藏
页码:437 / 449
页数:13
相关论文
共 50 条
  • [21] Public Health Policy Monitoring through Public Perceptions: A Case of COVID-19 Tweet Analysis
    Li, Chih-yuan
    Renda, Michael
    Yusuf, Fatima
    Geller, James
    Chun, Soon Ae
    INFORMATION, 2022, 13 (11)
  • [22] The effects of tax and fee reduction policy on mitigating shock of the COVID-19 epidemic in China
    Xu, Jin
    Wei, Weixian
    APPLIED ECONOMICS, 2021, 53 (46) : 5303 - 5318
  • [23] Public health leadership in the COVID-19 era: how does it fit? A scoping review
    Osti, Tommaso
    Gris, Angelica Valz
    Corona, Valerio Flavio
    Villani, Leonardo
    D'Ambrosio, Floriana
    Lomazzi, Marta
    Favaretti, Carlo
    Cascini, Fidelia
    Gualano, Maria Rosaria
    Ricciardi, Walter
    BMJ LEADER, 2024, 8 (02) : 174 - 182
  • [24] Spatial and Temporal Differences in the Health Expenditure Efficiency of China: Reflections Based on the Background of the COVID-19 Pandemic
    Shi, Yi
    Xie, Yufeng
    Chen, Huangxin
    Zou, Wenjie
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [25] Evaluating public opinions: informing public health policy adaptations in China amid the COVID-19 pandemic
    Chenyang Wang
    Xinzhi Wang
    Pei Wang
    Qing Deng
    Yi Liu
    Hui Zhang
    Scientific Reports, 14
  • [26] COVID-19 Prevention and Control Public Health Strategies in Shanghai, China
    Zhang, Ni
    Shi, Tianqin
    Zhong, Heng
    Guo, Yijia
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2020, 26 (04) : 334 - 344
  • [27] China's Changing COVID-19 Policies: Market and Public Health
    Xu, Zhun
    REVIEW OF RADICAL POLITICAL ECONOMICS, 2025, 57 (01) : 90 - 108
  • [28] China's public health diplomacy in the post Covid-19 era
    Zhao, Lei
    Wang, Bing
    JOURNAL OF CHINESE ECONOMIC AND BUSINESS STUDIES, 2022, 20 (03) : 235 - 244
  • [29] COVID-19: decision-making in public health
    de Caestecker, Linda
    von Wissmann, Beatrix
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2021, 51 : S26 - S32
  • [30] Spatial epidemic dynamics of the COVID-19 outbreak in China
    Kang, Dayun
    Choi, Hyunho
    Kim, Jong-Hun
    Choi, Jungsoon
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 94 : 96 - 102